Bridging Discovery & Clinical Translation: InoKey™ for Biomarker-Driven Drug Development

Blog Post | Biomarker-Driven Drug Development Originally posted on Scientist.com on February 4, 2025  Bridging Discovery & Clinical Translation: InoKey™ for Biomarker-Driven Drug Development While genomics and transcriptomics have transformed biomedical research, they do not always provide a complete picture of therapeutic response. Proteomics — measuring the dynamic state of proteins — bridges this gap, […]

Inoviv Announces FibroKey

Inoviv Announces FibroKey™: Advancing Non-Invasive Biomarker Monitoring for Fibrosis Research October 1, 2024 – London, UK – Inoviv (the “Company”) has announced the launch of FibroKey™, a cutting-edge, mass spectrometry-based assay designed to monitor fibrosis-related protein biomarkers with high precision. FibroKey™ is a quantitative multiplex assay developed to provide researchers and clinicians with non-invasive insights […]